[go: up one dir, main page]

BR9915693A - Composição compreendendo proteìna de soja, fibra de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de diabetes tipo 2, a sìdrome metabólica e doenças cardiovasculares associadas - Google Patents

Composição compreendendo proteìna de soja, fibra de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de diabetes tipo 2, a sìdrome metabólica e doenças cardiovasculares associadas

Info

Publication number
BR9915693A
BR9915693A BR9915693-8A BR9915693A BR9915693A BR 9915693 A BR9915693 A BR 9915693A BR 9915693 A BR9915693 A BR 9915693A BR 9915693 A BR9915693 A BR 9915693A
Authority
BR
Brazil
Prior art keywords
composition
soy protein
diabetes
cardiovascular diseases
prevention
Prior art date
Application number
BR9915693-8A
Other languages
English (en)
Inventor
Lars Henrik Hoie
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9915693(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Publication of BR9915693A publication Critical patent/BR9915693A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO COMPREENDENDO PROTEìNA DE SOJA, FIBRAS DE DIETA E UM COMPOSTO FITOESTROGêNIO E SEU USO NA PREVENçãO E/OU TRATAMENTO DE DIABETES TIPO 2, A SìNDROME METABóLICA E DOENçAS CARDIOVASCULARES ASSOCIADAS"<D>. Uma composição compreendendo (a) proteína de soja, (b) um composto fitoestrogênio, e (c) fibras de dieta. A proteína de soja (a) está presente em uma quantidade de pelo menos 45 porcento em peso do teor de proteína total da composição, o dito teor de proteína total provendo pelo menos 15 porcento do teor de energia total da composição. O composto fitoestrogênio (b) é preferivelmente uma isoflavona ocorendo naturalmente e está presente em uma quantidade de mais que 0,10 porcento em peso da proteína de soja, e as fibras de dieta (c) são preferivelmente fibras de soja e estão presentes em uma quantidade de mais que 4 porcento em peso do peso total da composição nutricional em uma base seca. A composição é útil para o tratamento de diabetes tipo 2 e doenças cardiovasculares em um sujeito diabético.
BR9915693-8A 1998-11-25 1999-11-25 Composição compreendendo proteìna de soja, fibra de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de diabetes tipo 2, a sìdrome metabólica e doenças cardiovasculares associadas BR9915693A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801556 1998-11-25
DKPA199900856 1999-06-16
PCT/IB1999/001992 WO2000030663A1 (en) 1998-11-25 1999-11-25 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases

Publications (1)

Publication Number Publication Date
BR9915693A true BR9915693A (pt) 2001-08-14

Family

ID=26064784

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915693-8A BR9915693A (pt) 1998-11-25 1999-11-25 Composição compreendendo proteìna de soja, fibra de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de diabetes tipo 2, a sìdrome metabólica e doenças cardiovasculares associadas

Country Status (9)

Country Link
EP (1) EP1143988B1 (pt)
JP (1) JP2003524610A (pt)
AT (1) ATE259646T1 (pt)
AU (1) AU1511300A (pt)
BR (1) BR9915693A (pt)
CA (1) CA2352510A1 (pt)
DE (1) DE69914947D1 (pt)
HK (1) HK1041636A1 (pt)
WO (1) WO2000030663A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733815B2 (en) 1999-04-16 2004-05-11 Cargill, Incorporated Food ingredient containing wheat gluten, soy grits and soy flour
EP1171119A1 (en) 1999-04-20 2002-01-16 The Board Of Trustees Of Southern Illinois University Methods of treating clinical diseases with isoflavones
AU783838B2 (en) * 1999-04-23 2005-12-15 Archer-Daniels-Midland Company Composition for and method of reducing low density lipoprotein cholesterol concentration
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US7285297B1 (en) 1999-04-23 2007-10-23 Archer-Daniels-Midland Company Method of reducing low density liproprotein cholesterol concentration
AU779014B2 (en) * 1999-04-23 2005-01-06 Archer-Daniels-Midland Company Composition for and method of reducing low density lipoprotein cholesterol concentration
ES2331724T3 (es) 2000-04-14 2010-01-14 Mars, Incorporated Composiciones y metodos para mejorar la salud vascular.
JP2011105763A (ja) * 2000-06-21 2011-06-02 Kao Corp Ｐｐａｒ依存的遺伝子転写活性化剤
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
EP1361870A2 (en) * 2001-02-01 2003-11-19 Nutri Pharma ASA A substance for use in a dietary supplement or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
FI20010780A0 (fi) 2001-04-12 2001-04-12 Raisio Benecol Oy Parannetut koostumukset
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
EP1443946A2 (en) * 2001-07-03 2004-08-11 Nutri Pharma ASA Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
GB0125662D0 (en) * 2001-10-26 2001-12-19 Chapman Thomas B Formultion
AU2003206050A1 (en) * 2002-02-22 2003-09-09 Nutri Pharma Asa Food products comprising soy protein
AU2003215774A1 (en) * 2002-02-23 2003-09-09 Nutri Pharma Asa Method for manufacturing beads containing exogenous soy protein
AU2003206049A1 (en) * 2002-02-23 2003-09-09 Nutri Pharma Asa Novel soy protein products
BRPI0309421B8 (pt) 2002-04-18 2021-05-25 Monsanto Technology Llc método de preparar um gênero alimentício e composição para tratar ou prevenir hipercolesterolemia
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
CN101965974A (zh) 2002-07-24 2011-02-09 儿童医院医疗中心 含有对映体牛尿酚的组合物和产物及其用途
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
CA2504682A1 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
JP2008007452A (ja) * 2006-06-28 2008-01-17 Ajinomoto Co Inc 膵β細胞保護剤
US20100183576A1 (en) * 2006-08-21 2010-07-22 Calpis Co., Ltd. Lipid-metabolism-ameliorating agent
DE102006040456A1 (de) * 2006-08-25 2008-02-28 Constantin Nies Verzehrbare flächige Darreichungsform von Nahrungsergänzungsmitteln und/oder Arzneiwirkstoffen zur Ergänzung von fertigen oder halbfertigen Nahrungsmitteln
US9101161B2 (en) 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
KR101567105B1 (ko) * 2007-06-13 2015-11-06 오츠카 세이야쿠 가부시키가이샤 에쿠올 함유 추출물 및 그의 제조방법, 에쿠올 추출 방법
JP2011006369A (ja) * 2009-06-29 2011-01-13 Kao Corp Ｐａｉ−１低下剤
US10631564B2 (en) 2015-06-19 2020-04-28 University Of Southern California Enterically coated microparticle compositions and methods for modified nutrient delivery
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system
USD767243S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767242S1 (en) 2015-09-03 2016-09-27 The J.M Smucker Company Coated food product
USD767241S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767244S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395288A1 (fr) * 1977-06-23 1979-01-19 Ppn Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
DK171752B1 (da) * 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
WO1997037547A1 (en) * 1996-04-09 1997-10-16 E.I. Du Pont De Nemours And Company Novel isoflavone-enriched soy protein product and method for its manufacture
WO1998003084A1 (en) * 1996-07-18 1998-01-29 Nutricor, Inc. Nutritious food preparations and methods for making them
ATE362715T1 (de) * 1997-06-23 2007-06-15 Nestle Sa Zusammensetzung zur ernährung von diabetikern

Also Published As

Publication number Publication date
WO2000030663A1 (en) 2000-06-02
AU1511300A (en) 2000-06-13
EP1143988A1 (en) 2001-10-17
CA2352510A1 (en) 2000-06-02
JP2003524610A (ja) 2003-08-19
ATE259646T1 (de) 2004-03-15
DE69914947D1 (de) 2004-03-25
EP1143988B1 (en) 2004-02-18
HK1041636A1 (zh) 2002-07-19

Similar Documents

Publication Publication Date Title
BR9915693A (pt) Composição compreendendo proteìna de soja, fibra de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de diabetes tipo 2, a sìdrome metabólica e doenças cardiovasculares associadas
BR9915689A (pt) Composição compreendendo proteìna de soja, fibras de dieta e um composto fitoestrogênio e seu uso na prevenção e/ou tratamento de doenças pulmonares
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
WO1999004748A3 (en) Skin care composition
EA199800779A1 (ru) Композиция на основе сои, используемая в качестве пищевой добавки или для снижения содержания липидов в сыворотке крови
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
BR9306178A (pt) Composiçoes para o tratamento das condiçoes de pele seca e cosmética uso da mesma e processo para aliviar ou melhorar as condiçoes de pele seca acne e caspa
ES2139678T5 (es) Uso de eritropoyetina para la preparacion de una composicion farmaceutica para administracion pulmonar o inhalacion.
SE8000469L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
MX167984B (es) Sucedaneos de grasas y aceites en alimentos de consumo humano
TR200103634T2 (tr) Bitkilerde flavonoidlerin ve fenolik maddelerin miktarını arttırma yöntemi.
Semaming et al. Protocatechuic acid restores vascular responses in rats with chronic diabetes induced by streptozotocin
BR0013353A (pt) Combinação de substância ativa com clonidina
FR2818148B1 (fr) Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
ATE219073T1 (de) Benzopyran derivate mit leukotrien- antagonistischer wirkung
DE69123363D1 (de) Neue zusammensetzungen
ATE309781T1 (de) Verwendung eines iridaceae-extrakts in einer zusammensetzung für die stimulierung der immunabwehr
BR0215109A (pt) Preparado de ervas aromáticas
BR0012573A (pt) Combinações de substâncias ativas fungicidas
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
RU96108689A (ru) Концентрат тонизирующего и общеукрепляющего быстрорастворимого напитка &#34;солэвит&#34;
KR200186405Y1 (ko) 성냥 이쑤시개
DE69909010D1 (de) Verwendung von procyanidolischen Oligomeren oder Anthocyanosiden als Anti-Urease Wirkstoffe
BG49742A1 (en) Affrodisiance means
BR8100174U (pt) Disposição construtiva em palmilha

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.

B15K Others concerning applications: alteration of classification

Ipc: A61K 36/48 (2006.01), A23L 33/10 (2016.0